Medifast Inc/ US58470H1014 /
| 2024-04-18 10:10:00 PM | Chg. +0.59 | Volume | Bid11:01:37 AM | Ask11:01:37 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 32.47USD | +1.85% | 304,151 Turnover: 6.42 mill. |
30.96Bid Size: 2,500 | 32.37Ask Size: 300 | 353.78 mill.USD | 15.24% | 3.56 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 26.0390 | 27.6330 | 56.1310 | 57.1850 | 51.4670 | ||||||
| Intangible Assets | - | - | - | - | - | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 40.5020 | 41.7700 | 91.4600 | 93.4290 | 85.8790 | ||||||
| Inventories | 48.7710 | 53.3920 | 180.0430 | 118.8560 | 54.5910 | ||||||
| Accounts Receivable | 1.4370 | .5840 | - | - | - | ||||||
| Cash and Cash Equivalents | 76.9740 | 163.7230 | 104.1830 | 87.6910 | 94.4400 | ||||||
| Current Assets | 154.1510 | 234.3140 | 306.8660 | 222.7840 | 224.0290 | ||||||
| Total Assets | 194.6530 | 276.0840 | 398.3260 | 316.2130 | 309.9080 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | - | - | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 89.8210 | 118.8380 | 195.8520 | 161.1690 | 108.4270 | ||||||
| Share Capital | .0120 | .0120 | .0120 | .0110 | .0110 | ||||||
| Total Equity | 104.8320 | 157.2460 | 202.4740 | 155.0440 | 201.4810 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 194.6530 | 276.0840 | 398.3260 | 316.2130 | 309.9080 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 713.6720 | 934.8420 | 1,526.0870 | 1,598.5770 | 1,072.0540 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 91.0390 | 134.1590 | 216.2410 | 184.8060 | 126.4020 | ||||||
| Interest Income | 1.2950 | .2460 | -.2310 | -.7010 | 2.4900 | ||||||
| Income Before Taxes | 92.3630 | 134.2650 | 216.1290 | 184.0590 | 128.7970 | ||||||
| Income Taxes | 14.4470 | 31.4060 | 52.0980 | 40.4910 | 29.3820 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 77.9160 | 102.8590 | 164.0310 | 143.5680 | 99.4150 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 84.2610 | 145.1960 | 94.5450 | 194.5700 | 147.6570 | ||||||
| Cash Flow from Investing Activities | -6.3280 | -1.2820 | -29.0640 | -11.4140 | -61.0470 | ||||||
| Cash Flow from Financing | -82.3240 | -57.1440 | -125.1330 | -199.5810 | -79.7890 | ||||||
| Decrease / Increase in Cash | -4.3900 | 86.7490 | -59.5400 | -16.4920 | 6.7490 | ||||||
| Employees | 550 | - | - | - | - | ||||||
